0001104659-22-092022.txt : 20220817 0001104659-22-092022.hdr.sgml : 20220817 20220817090031 ACCESSION NUMBER: 0001104659-22-092022 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220812 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220817 DATE AS OF CHANGE: 20220817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mallinckrodt plc CENTRAL INDEX KEY: 0001567892 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981088325 FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35803 FILM NUMBER: 221172206 BUSINESS ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 BUSINESS PHONE: 353 1 6960000 MAIL ADDRESS: STREET 1: COLLEGE BUSINESS & TECHNOLOGY PARK STREET 2: CRUISERATH, BLANCHARDSTOWN CITY: DUBLIN 15 STATE: L2 ZIP: D15 8-K 1 tm2223494d1_8k.htm FORM 8-K
0001567892 false 0001567892 2022-08-12 2022-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

 

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the 

Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): August 12, 2022

 

Mallinckrodt plc 

(Exact name of registrant as specified in its charter)

 

Ireland 001-35803 98-1088325
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

 

College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland 
(Address of principal executive offices)

 

+353 1 6960 000 

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of Karen Ling

 

On August 12, 2022, the Board of Directors (the “Board”) of Mallinckrodt plc (the “Company” or “Mallinckrodt”) appointed Karen L. Ling as a director of Mallinckrodt, to serve until the end of the Company’s 2022 Annual General Meeting or, if earlier, her resignation, removal or death.

 

Ms. Ling most recently served as Executive Vice President and Chief Human Resources Officer for American International Group, Inc., a position she retired from in May 2021 and had held since July 2019. From March 2015 until July 2019, she served as Executive Vice President and Chief Human Resources Officer at Allergan plc. From July 2014 until March 2015, Ms. Ling served as Senior Vice President, Human Resources and Chief Human Resources Officer at Actavis plc, prior to its acquisition of Allergan and name change to Allergan. From January 2014 until July 2014, Ms. Ling was Senior Vice President and Chief Human Resources Officer at Forest Laboratories, prior to its acquisition by Actavis. Prior to this, from 2011 until January 2014, Ms. Ling was Senior Vice President, Human Resources of the Global Human Health and Consumer Care businesses worldwide for Merck & Co., Inc. She also served as Vice President, Global Compensation and Benefits, at Merck from November 2009 until 2011. From May 2008 until November 2009, she served as Group Vice President, Global Compensation & Benefits at Schering-Plough, prior to its acquisition by Merck. Prior to joining Schering-Plough, Ms. Ling held various positions at Wyeth, LLC.

 

In addition to the Mallinckrodt Board, Ms. Ling serves as a director on the board of iRhythm Technologies, Inc. and TherapeuticsMD, Inc., positions she has held since 2021 and 2020, respectively. Ms. Ling holds a BA in Economics from Yale University and a JD from Boston University School of Law. Ms. Ling’s qualifications to serve on the Board include her extensive experience in human resources and past leadership roles at publicly traded pharmaceutical companies.

 

There are no transactions between Ms. Ling, on the one hand, and Mallinckrodt, on the other hand, that would be reportable under Item 404(a) of Regulation S-K, and no arrangements or understandings between Ms. Ling and any other persons pursuant to which she was selected to the Board.

 

Ms. Ling will receive compensation as a non-employee director of the Board as follows:

 

Cash Retainers

 

·Board Members. Each non-employee director receives an annual cash retainer of $75,000, paid in quarterly installments at the beginning of each quarter.

 

·Committee Chairs. The Chair of the Audit Committee receives a supplemental annual cash retainer of $25,000. The Chair of the Human Resources and Compensation Committee and the Governance and Compliance Committee will each receive a supplemental annual cash retainer of $17,500.

 

·Committee Members. Each member of the Audit Committee (excluding the chair) receives a supplemental annual cash retainer of $15,000. Each member of the Human Resources and Compensation Committee and the Governance and Compliance Committee (excluding the chairs) receives a supplemental annual cash retainer of $10,500.

 

·In addition, each non-employee director receives $1,500 for each meeting attended that is in excess of 10 meetings (including meetings of the Board and each committee of the Board).

 

 

 

  

Equity Awards

 

·Restricted Stock Units (“RSUs”). Within 15 days after her appointment to the Board, Ms. Ling will receive a grant of 26,276 RSUs, which grant of RSUs will vest ratably on each of the first two anniversaries of Mallinckrodt’s emergence from Chapter 11 proceedings on June 16, 2022. Ms. Ling will also receive a grant of 26,277 RSUs as soon as reasonably practicable following January 1, 2023, subject to her continued service through such date and any applicable limit on director grants under the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan, which RSUs are expected to vest ratably on each of the first two anniversaries of Mallinckrodt's emergence from Chapter 11 proceedings.

 

Item 7.01. Regulation FD Disclosure.

 

On August 17, 2022, Mallinckrodt issued a press release announcing the appointment of Ms. Ling to its board of directors. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

  

The information contained in this Item 7.01, including Exhibit 99.1, shall be deemed to be “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)            Exhibits.

 

Exhibit No.   Description of Exhibit
99.1   Press Release, dated August 17, 2022.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MALLINCKRODT PLC
 
Dated: August 17, 2022 By: /s/ Mark Tyndall
    Mark Tyndall
    Executive Vice President, Chief Legal Officer & Corporate Secretary

 

 

 

 EX-99.1 2 tm2223494d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

 

Mallinckrodt Announces Appointment of Karen Ling to Its Board of Directors

 

DUBLIN, August 17, 2022 – Mallinckrodt plc (OTCMKTS: MNKPF) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today announced that Karen Ling has been appointed to the Company’s Board of Directors, effective August 12, 2022. With the addition of Ms. Ling, the Mallinckrodt Board will expand to eight directors, seven of whom are independent.

 

“We are thrilled to welcome a leader of Karen’s caliber to the Mallinckrodt Board,” said Paul Bisaro, Chairman of the Mallinckrodt Board of Directors. “Karen is an accomplished global human resources executive, with decades of experience and a proven record of helping lead companies through times of transition and transformation, creating and implementing performance-driven compensation and benefits programs, and enhancing corporate culture initiatives. I am confident that we will benefit from her expertise and guidance on the Board as we look at ways to strengthen our organization and drive employee engagement around meeting our business objectives and continuing to put patients first.”

 

“I have great admiration for the work Mallinckrodt does to serve patients, and I am honored to join Mallinckrodt at such an important time for the Company,” said Ms. Ling. “Together with my fellow directors and the management team, I am excited to help guide Mallinckrodt as it re-energizes its teams, renews its focus on making a positive impact on the lives of patients and drives shareholder value creation.”

 

Ms. Ling has more than 25 years of experience in human resources leadership and has worked extensively in the pharmaceutical industry. She most recently served as Executive Vice President and Chief Human Resources Officer of American International Group, Inc. (AIG) from 2019 to 2021, leading the Company’s global human resources function. Prior to AIG, Ms. Ling served as Executive Vice President and Chief Human Resources Officer at Allergan from 2014 to 2019. From 2008 to 2014, Ms. Ling held a number of leadership positions at Merck, culminating in her role as Senior Vice President, Human Resources for Merck’s Global Human Health and Consumer Care businesses. Prior to Merck, she spent 14 years at Wyeth in various positions leading human resources in the company’s pharmaceutical division and subsequently at the corporate level. Throughout her career, Ms. Ling has led the integration of successive acquisitions, enhanced compensation and benefits programs, implemented initiatives to strengthen corporate culture, and evolved and improved talent acquisition and retention practices.

 

Ms. Ling serves on the boards of iRhythm Technologies and TherapeuticsMD, where she chairs the Compensation Committee. She also serves on the advisory committee of Galderma and the boards of two non-profit organizations, ExpandED and the JED Foundation.

 

Ms. Ling holds a J.D. from Boston University and a B.A. in Economics from Yale University.

 

About Mallinckrodt

 

Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The Company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit www.mallinckrodt.com.

 

 

 

 

Mallinckrodt uses its website as a channel of distribution of important company information, such as press releases, investor presentations and other financial information. It also uses its website to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the U.S. Securities and Exchange Commission (SEC) disclosing the same information. Therefore, investors should look to the Investor Relations page of the website for important and time-critical information. Visitors to the website can also register to receive automatic e-mail and other notifications alerting them when new information is made available on the Investor Relations page of the website.

 

CAUTIONARY STATEMENTS RELATED TO FORWARD-LOOKING STATEMENTS

 

Statements in this document that are not strictly historical, including statements regarding Mallinckrodt’s future financial condition and operating results, legal, economic, business, competitive and/or regulatory factors affecting Mallinckrodt’s businesses, and any other statements regarding events or developments Mallinckrodt believes or anticipates will or may occur in the future, may be “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, and involve a number of risks and uncertainties. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. The “Risk Factors” section of Mallinckrodt’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and other filings with the SEC identify and describe in more detail the risks and uncertainties to which Mallinckrodt’s businesses are subject. The forward-looking statements made herein speak only as of the date hereof and Mallinckrodt does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise, except as required by law.

 

CONTACTS 

Investor Relations 

Daniel J. Speciale 

Global Corporate Controller and Chief Investor Relations Officer 

314-302-6567 

daniel.speciale@mnk.com

 

Derek Belz 

Vice President, Investor Relations 

314-654-3950 

derek.belz@mnk.com

 

Media 

Michael Freitag / Aaron Palash / Aura Reinhard 

Joele Frank, Wilkinson Brimmer Katcher 

(212) 355-4449

 

Mallinckrodt, the "M" brand mark and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2022 08/22.

 

 

 

 EX-101.SCH 3 mnk-20220812.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mnk-20220812_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 mnk-20220812_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2223494d1_ex99-1img001.jpg GRAPHIC begin 644 tm2223494d1_ex99-1img001.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover
Aug. 12, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 12, 2022
Entity File Number 001-35803
Entity Registrant Name Mallinckrodt plc
Entity Central Index Key 0001567892
Entity Tax Identification Number 98-1088325
Entity Incorporation, State or Country Code L2
Entity Address, Address Line One College Business & Technology Park
Entity Address, Address Line Two Cruiserath
Entity Address, Address Line Three Blanchardstown
Entity Address, City or Town Dublin
Entity Address, Country IE
Entity Address, Postal Zip Code 15
Country Region 353
City Area Code 1
Local Phone Number 6960 000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
XML 8 tm2223494d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001567892 2022-08-12 2022-08-12 iso4217:USD shares iso4217:USD shares 0001567892 false 8-K 2022-08-12 Mallinckrodt plc L2 001-35803 98-1088325 College Business & Technology Park Cruiserath Blanchardstown Dublin 15 IE 353 1 6960 000 false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://mallinckrodt.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2223494d1_8k.htm mnk-20220812.xsd mnk-20220812_lab.xml mnk-20220812_pre.xml tm2223494d1_ex99-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2223494d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm2223494d1_8k.htm" ] }, "labelLink": { "local": [ "mnk-20220812_lab.xml" ] }, "presentationLink": { "local": [ "mnk-20220812_pre.xml" ] }, "schema": { "local": [ "mnk-20220812.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "mnk", "nsuri": "http://mallinckrodt.com/20220812", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2223494d1_8k.htm", "contextRef": "From2022-08-12to2022-08-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://mallinckrodt.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2223494d1_8k.htm", "contextRef": "From2022-08-12to2022-08-12", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://mallinckrodt.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001104659-22-092022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-092022-xbrl.zip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end